CAS 156161-89-6
:B Q-788
Description:
B Q-788, identified by its CAS number 156161-89-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective antagonist of certain receptors, which may contribute to its pharmacological effects. The compound is typically studied for its role in modulating biological pathways, potentially influencing conditions related to cardiovascular health and other physiological processes. Its molecular structure includes specific functional groups that enhance its binding affinity and selectivity for target receptors. Additionally, B Q-788's solubility, stability, and bioavailability are important factors that influence its efficacy and safety profile in research settings. As with many compounds in this category, ongoing studies aim to elucidate its mechanism of action, therapeutic potential, and any associated side effects, contributing to a better understanding of its role in drug development and clinical applications.
Formula:C34H50N5O7·Na
InChI:InChI=1/C34H51N5O7.Na/c1-8-9-16-25(31(42)43)35-29(40)26(18-23-20-38(33(45)46-7)28-17-11-10-15-24(23)28)36-30(41)27(19-34(4,5)6)37-32(44)39-21(2)13-12-14-22(39)3;/h10-11,15,17,20-22,25-27H,8-9,12-14,16,18-19H2,1-7H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43);/q;+1/p-1/t21-,22+,25-,26-,27+;/m1./s1
InChI key:InChIKey=IASLQTYUGYPLFB-FUKQNADPSA-N
SMILES:C([C@@H](NC([C@@H](NC(=O)N1[C@@H](C)CCC[C@H]1C)CC(C)(C)C)=O)C(N[C@H](CCCC)C(O)=O)=O)C=2C=3C(N(C(OC)=O)C2)=CC=CC3.[Na]
Synonyms:- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[(cis-2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl-, monosodium salt
- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[N-[N-[(2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl]-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl]-, monosodium salt, cis-
- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl-, monosodium salt
- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl-, sodium salt (1:1)
- BQ-788, Sodium Salt
- Bq 788
- sodium (2R)-2-{[(2S)-2-({[(2R,6S)-2,6-dimethylpiperidin-1-yl]carbonyl}amino)-4,4-dimethylpentanoyl][1-(methoxycarbonyl)-D-tryptophyl]amino}hexanoate
- sodium N-{[(2R,6S)-2,6-dimethylpiperidin-1-yl]carbonyl}-4-methyl-L-leucyl-N-[(1R)-1-carboxylatopentyl]-1-(methoxycarbonyl)-D-tryptophanamide
- D-Norleucine, N-[(cis-2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-, monosodium salt
- D-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-, sodium salt (1:1)
- D-Norleucine, N-[N-[N-[(2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl]-1-(methoxycarbonyl)-D-tryptophyl]-, monosodium salt, cis-
- D-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-, monosodium salt
- sodium,(2R)-2-[[(2R)-2-amino-3-(1-methoxycarbonylindol-3-yl)propanoyl]-[(2S)-2-[[(2R,6S)-2,6-dimethylpiperidine-1-carbonyl]amino]-4,4-dimethylpentanoyl]amino]hexanoate
- BQ-788 SYNTHETIC >97% ETB ENDOTHELIN REC EPT
- N-[N-[N-[(2,6-Dimethyl-1-piperidinyl)carbonyl]-
- 2,6-Dimethylpiperidinecarbonyl-γ-Methyl-Leu-Nin-(Methoxycarbonyl)-D-Trp-D-Nle
- N-cis-2,6-dimethylpiperidinocarbonyl-L-γMeLeu-D-Trp(COOMe)-D-Nle-ONa
- BQ788 SODIUM SALT; BQ 788 SODIUM SALT
- DMpc-gaMMa-MeLeu-D-Trp(1-CO2CH3)-D-Nle.Na (DMpc : cis-2,6-DiMethylpiperidinocarbonyl)
- N-[(cis-2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-D-norleucinesodiumsalt
- N-[N-[N-[(2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl]-1-(methoxycarbonyl)-D-tryptophyl]-D-norleucine sodium salt, 2,6-Dimethylpiperidinecarbonyl-γ-Methyl-Leu-Nin-(Methoxycarbonyl)-D-Trp-D-Nle
- BQ789 Sodium Salt
- N-[N-[N-[(2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl]-1-(methoxycarbonyl)-D-tryptophyl]-D-norleucine sodium salt
- 1-ELAIDYLPHOSPHOCHOLINE, >97%
- BQ-788 SODIUM
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Sodium (R)-2-((R)-2-((S)-2-((2R,6S)-2,6-dimethylpiperidine-1-carboxamido)-4,4-dimethylpentanamido)-3-(1-(methoxycarbonyl)-1H-indol-3-yl)propanamido)hexanoate
CAS:Sodium (R)-2-((R)-2-((S)-2-((2R,6S)-2,6-dimethylpiperidine-1-carboxamido)-4,4-dimethylpentanamido)-3-(1-(methoxycarbonyl)-1H-indol-3-yl)propanamido)hexanoatePurity:98%Molecular weight:663.79g/molBQ-788 sodium salt
CAS:BQ-788 sodium salt is a potent and selective antagonist of ETB receptor(ETB receptors with an IC50 of 1.2 nM in human Girrardi heart cells).Formula:C34H51N5NaO7Color and Shape:SolidMolecular weight:664.8BQ 788
CAS:<p>Applications BQ 788 is an endothelin type B (ETB) receptor antagonist and is a potential antidote for the cardiovascular toxicity with hypotension and bradycardia.<br>References Arici, M.A.A., et. al.: Hum. Exp. Toxicol., 32, 316 (2013)<br></p>Formula:C34H50N5O7·NaColor and Shape:NeatMolecular weight:663.78





